• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Clinical Trials

Diabetes: Medtronic furthers the quest for an artificial pancreas

June 15, 2015 By Fink Densford

Medtronic (NYSE:MDT) and Intarcia Therapeutics were in the spotlight at the American Diabetes Assn.’s annual scientific sessions conference in Boston last week, revealing new medical device developments in the fight against diabetes. Medtronic took center stage, announcing new developments for its artificial pancreas program, touting positive data from a user study of its MiniMed 640g and revealing plans to collaborate […]

Filed Under: Clinical Trials, Drug-Device Combinations, Research & Development Tagged With: Becton Dickinson, GI Dynamics, Glytec, Intarcia Therapeutics, Medtronic, Valeritas Inc.

Avedro application needs more work, FDA says

March 18, 2014 By drugdelivery

Avedro application need more work, FDA says

Massachusetts ophthalmic devices maker Avedro has some issues to address before the company can move forward with an FDA New Drug Application for its light-based cross-linking product for treatment.

Filed Under: Clinical Trials, Drug-Device Combinations Tagged With: Avedro Inc., New Drug Application (NDA)

Covidien launches 2 trials to support its Stellarex drug-device combo

July 17, 2013 By drugdelivery

Covidien launched 2 trials to support its Stellarex drug-device combo

Covidien (NYSE:COV) kicked off 2 new clinical trials this week to support a global evaluation of its Stellarex drug-coated angioplasty balloon.

Filed Under: Clinical Trials, Drug-Device Combinations Tagged With: Clinical Trials, Covidien, Peripheral Artery Disease

Echo Therapeutics readies Prelude SkinPrep for clinical trials

January 11, 2010 By drugdelivery

Echo Therapeutics Inc. (OTC:ECTE) reached a milestone with one of its two flagship products, the Prelude SkinPrep system, which is ready for clinical trials examining its use in dispensing lidocaine.

The Franklin, Mass.-based company, which is also developing a needle-free glucose monitoring system called the Symphony tCGM, said its development work on the Prelude system is complete and it’s ready for a study in the “near term.”

Filed Under: Business/Financial News, Clinical Trials, Diagnostics, Drug-Device Combinations Tagged With: Echo Therapeutics Inc.

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 69
  • Go to page 70
  • Go to page 71

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS